Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2026-08-19 16:30:03 ET · period of report 2026-08-17 · accession 0001923794-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-19 16:30 | 2026-08-17 | CADL | Tyagarajan Seshu | CTO | S - Sale | $12.00 | -7,000 | 76.9K | -8% | -$84.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-17 | S | D | 7,000 | $12.00 | 76,865 | D | — | — | (F1) This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 3/16/2026. |